title: Predicting neonatal respiratory morbidity by lamellar body count and gestational age.
abstract: OBJECTIVE
  To develop a predictive model for assessing the risk of developing neonatal respiratory morbidity using lamellar body counts (LBCs) and gestational age (GA) to provide a more patient-specific assessment.
  
  
  METHODS
  Retrospective cohort study of patients' ≥32 weeks' gestation who received amniocentesis with LBC analysis over a 9-year period. Respiratory morbidity was defined as respiratory distress syndrome, transient tachypnea of the newborn or oxygen requirement for >24 h. Logistic regression analyses were used to predict the absolute risk and odds of respiratory morbidity as a function of GA and lamellar body count.
  
  
  RESULTS
  Two hundred and sixty-seven mother-infant pairs included in the analysis with 32 cases (12.0%) of respiratory morbidity. When compared to those without respiratory morbidity, neonates with respiratory morbidity had amniocentesis performed at an earlier median GA, had lower mean birthweight and had lower median LBC (P<0.01). The GA specific absolute risks and odds ratios for the presence of respiratory morbidity were calculated. The predicted absolute risks of neonatal respiratory morbidity ranged from 38% at 32 weeks to 6% at 40 weeks when LBC were 35,000/μL.
  
  
  CONCLUSIONS
  GA specific predicted risk of neonatal respiratory morbidity using LBC provides a statistical model, which can aid clinicians in individually counseling patients regarding the absolute risk of their neonate developing respiratory morbidity.
authors.forename: Carmen
authors.initials: C
authors.lastname: Beamon
authors.forename: Laura
authors.initials: L
authors.lastname: Carlson
authors.forename: Brooke
authors.initials: B
authors.lastname: Rambally
authors.forename: Samuel
authors.initials: S
authors.lastname: Berchuck
authors.forename: Margaret
authors.initials: M
authors.lastname: Gearhart
authors.forename: Catherine
authors.initials: C
authors.lastname: Hammett-Stabler
authors.forename: Robert
authors.initials: R
authors.lastname: Strauss
mesh_terms: D000649:Amniocentesis; D000653:Amniotic Fluid / Q000378:metabolism*; D015415:Biomarkers / Q000378:metabolism; D003661:Decision Support Techniques; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D016015:Logistic Models; D016017:Odds Ratio; D010743:Phospholipids / Q000378:metabolism*; D012127:Respiratory Distress Syndrome, Newborn / Q000175:diagnosis* / Q000378:metabolism; D012189:Retrospective Studies; D018570:Risk Assessment; D059246:Tachypnea / Q000175:diagnosis* / Q000378:metabolism
chemical_list: D015415:Biomarkers; D010743:Phospholipids